Unigestion Holding SA Has $8.61 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Unigestion Holding SA cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 55.3% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 17,015 shares of the healthcare conglomerate’s stock after selling 21,044 shares during the period. Unigestion Holding SA’s holdings in UnitedHealth Group were worth $8,607,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group in the fourth quarter worth $30,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $30,000. Finally, Promus Capital LLC bought a new position in UnitedHealth Group in the 4th quarter valued at about $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $524.94 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company’s fifty day moving average price is $509.24 and its two-hundred day moving average price is $542.12. The company has a market cap of $480.17 billion, a price-to-earnings ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.83 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on UNH. Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Barclays decreased their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Finally, KeyCorp reaffirmed an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.